Edition:
India

People: Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

216.77USD
25 Sep 2020
Change (% chg)

$4.94 (+2.33%)
Prev Close
$211.83
Open
$210.89
Day's High
$217.46
Day's Low
$210.71
Volume
60,119
Avg. Vol
91,317
52-wk High
$228.69
52-wk Low
$95.79

Smith, David 

Mr. David Ross Smith serves as Chief Financial Officer, Corporate Executive Vice President of the Company. He has served as our Corporate Executive Vice President and Chief Financial Officer since August 2015. He joined us as Corporate Vice President, Discovery Services through our acquisition of Argenta and BioFocus from Galapagos NV in March 2014 and was promoted to Corporate Senior Vice President, Global Discovery Services, in October 2014. At Galapagos, he served in various capacities, including as Chief Executive Officer of its Galapagos Services division and as Chief Financial Officer. Mr. Smith served as Chief Financial Officer for Cambridge University Hospitals from 2007 to 2013. Mr. Smith spent eight years at PricewaterhouseCoopers prior to joining AstraZeneca in 1997, where he spent the next nine years in various finance and business roles of increasingly greater responsibility.

Basic Compensation

Total Annual Compensation, USD 554,467
Restricted Stock Award, USD 1,807,000
Long-Term Incentive Plans, USD --
All Other, USD 1,145,830
Fiscal Year Total, USD 3,507,300

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Foster

17,722,100

David Smith

3,507,300

William Barbo

2,576,390

Birgit Girshick

2,988,000

Joseph LaPlume

3,009,510

George Milne

344,856
As Of  28 Dec 2019